Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis

by Yara Dadalti Fragoso, Soniza Vieira Alves-Leon, Jefferson Becker, Joseph Bruno Bidin Brooks, Eber Castro Correa, Alfredo Damasceno, Paulo Diniz da Gama, Rodrigo Assad da Gama, Andre Palma da Cunha Matta, Ernane Pires Maciel, Thereza Cristina d’Avila Winckler
Published 2016-08-01